vs
Side-by-side financial comparison of Aterian, Inc. (ATER) and STRATA Skin Sciences, Inc. (SSKN). Click either name above to swap in a different company.
Aterian, Inc. is the larger business by last-quarter revenue ($15.1M vs $9.3M, roughly 1.6× STRATA Skin Sciences, Inc.). STRATA Skin Sciences, Inc. runs the higher net margin — 0.6% vs -52.5%, a 53.1% gap on every dollar of revenue. On growth, STRATA Skin Sciences, Inc. posted the faster year-over-year revenue change (-3.0% vs -38.5%). STRATA Skin Sciences, Inc. produced more free cash flow last quarter ($-551.0K vs $-1.0M). Over the past eight quarters, STRATA Skin Sciences, Inc.'s revenue compounded faster (17.3% CAGR vs -13.5%).
Aterian, Inc. is a technology-enabled consumer products company that leverages artificial intelligence and data analytics to identify market demand, develop, source and distribute a wide portfolio of affordable goods spanning home improvement, wellness, personal care, pet supplies and outdoor recreation. It primarily sells its products through leading global e-commerce platforms, with core markets covering North America and Europe.
Strata Skin Sciences is an American medical device company focused on the design, development and commercialization of non-invasive tools to provide additional information to dermatologists during melanoma skin examinations.
ATER vs SSKN — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $15.1M | $9.3M |
| Net Profit | $-7.9M | $58.0K |
| Gross Margin | 56.1% | 61.8% |
| Operating Margin | -51.1% | 5.3% |
| Net Margin | -52.5% | 0.6% |
| Revenue YoY | -38.5% | -3.0% |
| Net Profit YoY | -512.2% | 101.3% |
| EPS (diluted) | — | $0.14 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $15.1M | $9.3M | ||
| Q3 25 | $19.0M | $6.9M | ||
| Q2 25 | $19.5M | $7.7M | ||
| Q1 25 | $15.4M | $6.8M | ||
| Q4 24 | $24.6M | $9.6M | ||
| Q3 24 | $26.2M | $8.8M | ||
| Q2 24 | $28.0M | $8.4M | ||
| Q1 24 | $20.2M | $6.8M |
| Q4 25 | $-7.9M | $58.0K | ||
| Q3 25 | $-2.3M | $-1.6M | ||
| Q2 25 | $-4.9M | $-2.6M | ||
| Q1 25 | $-3.9M | $-2.1M | ||
| Q4 24 | $-1.3M | $-4.6M | ||
| Q3 24 | $-1.8M | $-2.1M | ||
| Q2 24 | $-3.6M | $-91.0K | ||
| Q1 24 | $-5.2M | $-3.4M |
| Q4 25 | 56.1% | 61.8% | ||
| Q3 25 | 56.1% | 60.4% | ||
| Q2 25 | 54.3% | 56.2% | ||
| Q1 25 | 61.4% | 53.5% | ||
| Q4 24 | 63.4% | 61.4% | ||
| Q3 24 | 60.3% | 60.1% | ||
| Q2 24 | 60.4% | 59.0% | ||
| Q1 24 | 65.1% | 45.6% |
| Q4 25 | -51.1% | 5.3% | ||
| Q3 25 | -10.7% | -16.9% | ||
| Q2 25 | -23.1% | -30.1% | ||
| Q1 25 | -24.1% | -25.0% | ||
| Q4 24 | -6.5% | -44.7% | ||
| Q3 24 | -6.6% | -18.2% | ||
| Q2 24 | -11.5% | -5.7% | ||
| Q1 24 | -26.1% | -42.7% |
| Q4 25 | -52.5% | 0.6% | ||
| Q3 25 | -12.0% | -23.4% | ||
| Q2 25 | -25.0% | -33.6% | ||
| Q1 25 | -25.4% | -31.2% | ||
| Q4 24 | -5.3% | -47.6% | ||
| Q3 24 | -6.8% | -23.6% | ||
| Q2 24 | -13.0% | -1.1% | ||
| Q1 24 | -25.5% | -49.8% |
| Q4 25 | — | $0.14 | ||
| Q3 25 | — | $-0.36 | ||
| Q2 25 | — | $-0.62 | ||
| Q1 25 | — | $-0.51 | ||
| Q4 24 | — | $-2.01 | ||
| Q3 24 | — | $-0.51 | ||
| Q2 24 | — | $-0.03 | ||
| Q1 24 | — | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.9M | $7.9M |
| Total DebtLower is stronger | — | $15.3M |
| Stockholders' EquityBook value | $15.2M | $2.9M |
| Total Assets | $29.6M | $30.5M |
| Debt / EquityLower = less leverage | — | 5.28× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.9M | $7.9M | ||
| Q3 25 | $7.6M | $7.1M | ||
| Q2 25 | $10.5M | $6.0M | ||
| Q1 25 | $14.3M | $6.5M | ||
| Q4 24 | $18.0M | $7.3M | ||
| Q3 24 | $16.1M | $7.1M | ||
| Q2 24 | $20.3M | $5.5M | ||
| Q1 24 | $17.5M | $5.2M |
| Q4 25 | — | $15.3M | ||
| Q3 25 | — | $15.3M | ||
| Q2 25 | — | $15.0M | ||
| Q1 25 | — | $15.0M | ||
| Q4 24 | — | $15.0M | ||
| Q3 24 | — | $15.0M | ||
| Q2 24 | — | $15.0M | ||
| Q1 24 | — | $15.0M |
| Q4 25 | $15.2M | $2.9M | ||
| Q3 25 | $22.6M | $1.3M | ||
| Q2 25 | $24.3M | $532.0K | ||
| Q1 25 | $27.0M | $3.0M | ||
| Q4 24 | $30.0M | $5.0M | ||
| Q3 24 | $30.6M | $9.4M | ||
| Q2 24 | $30.9M | $9.5M | ||
| Q1 24 | $33.0M | $9.4M |
| Q4 25 | $29.6M | $30.5M | ||
| Q3 25 | $40.1M | $30.7M | ||
| Q2 25 | $45.4M | $29.5M | ||
| Q1 25 | $49.8M | $33.0M | ||
| Q4 24 | $49.5M | $34.9M | ||
| Q3 24 | $52.1M | $39.4M | ||
| Q2 24 | $59.9M | $38.8M | ||
| Q1 24 | $55.7M | $39.2M |
| Q4 25 | — | 5.28× | ||
| Q3 25 | — | 11.65× | ||
| Q2 25 | — | 28.20× | ||
| Q1 25 | — | 5.04× | ||
| Q4 24 | — | 3.02× | ||
| Q3 24 | — | 1.60× | ||
| Q2 24 | — | 1.58× | ||
| Q1 24 | — | 1.59× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.0M | $-239.0K |
| Free Cash FlowOCF − Capex | $-1.0M | $-551.0K |
| FCF MarginFCF / Revenue | -6.9% | -5.9% |
| Capex IntensityCapex / Revenue | 0.0% | 3.4% |
| Cash ConversionOCF / Net Profit | — | -4.12× |
| TTM Free Cash FlowTrailing 4 quarters | — | $-4.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-1.0M | $-239.0K | ||
| Q3 25 | $-1.6M | $-64.0K | ||
| Q2 25 | $-4.4M | $-1.9M | ||
| Q1 25 | $-3.9M | $-550.0K | ||
| Q4 24 | $-9.0K | $703.0K | ||
| Q3 24 | $-722.0K | $-302.0K | ||
| Q2 24 | $2.9M | $591.0K | ||
| Q1 24 | $-6.0K | $-804.0K |
| Q4 25 | $-1.0M | $-551.0K | ||
| Q3 25 | $-1.6M | $-1.1M | ||
| Q2 25 | $-4.4M | $-2.0M | ||
| Q1 25 | — | $-749.0K | ||
| Q4 24 | — | $199.0K | ||
| Q3 24 | — | $-364.0K | ||
| Q2 24 | $2.9M | $246.0K | ||
| Q1 24 | $-42.0K | $-1.5M |
| Q4 25 | -6.9% | -5.9% | ||
| Q3 25 | -8.4% | -15.6% | ||
| Q2 25 | -22.7% | -26.1% | ||
| Q1 25 | — | -11.0% | ||
| Q4 24 | — | 2.1% | ||
| Q3 24 | — | -4.1% | ||
| Q2 24 | 10.3% | 2.9% | ||
| Q1 24 | -0.2% | -22.6% |
| Q4 25 | 0.0% | 3.4% | ||
| Q3 25 | 0.2% | 14.7% | ||
| Q2 25 | 0.0% | 0.8% | ||
| Q1 25 | 0.0% | 2.9% | ||
| Q4 24 | 0.0% | 5.3% | ||
| Q3 24 | 0.0% | 0.7% | ||
| Q2 24 | 0.0% | 4.1% | ||
| Q1 24 | 0.2% | 10.7% |
| Q4 25 | — | -4.12× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ATER
| Sales Channel Directly To Consumer | $13.1M | 87% |
| Heating Cooling And Air Quality | $2.1M | 14% |
SSKN
| Dermatology Recurring Procedures | $6.1M | 65% |
| Dermatology Procedures Equipment | $3.2M | 35% |
